ADMA Biologics (ADMA) said Friday it has made a $30 million paydown for its $62.5 million senior secured term loan facility with Ares Capital (ARCC) using cash on hand.
With the partial repayment, the company said it reduced its total gross debt by 29% to $75 million.
Price: 17.78, Change: -0.12, Percent Change: -0.67
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments